Larry S. McDaniel focuses on Microbiology, Streptococcus pneumoniae, Virology, Pneumococcal infections and Virulence. His research in Microbiology intersects with topics in Antibody, Protein A, Recombinant DNA and Antigen. His Streptococcus pneumoniae research is multidisciplinary, incorporating perspectives in Epitope and Immune system.
His study in Virology focuses on Serotype in particular. His research integrates issues of Immunology and Pneumolysin in his study of Pneumococcal infections. The Virulence study combines topics in areas such as Optochin, Escherichia coli and Pathogenic bacteria, Bacteria.
Larry S. McDaniel mostly deals with Microbiology, Streptococcus pneumoniae, Virology, Immunology and Antibody. Larry S. McDaniel has researched Microbiology in several fields, including Gene, Recombinant DNA, Virulence and Epitope, Antigen. His Streptococcus pneumoniae research includes themes of Serotype, Immune system and Streptococcaceae.
His Virology research is multidisciplinary, incorporating elements of Virulence factor, Plasmid, DNA, Bacterial capsule and Immunogenicity. In his work, Congenic is strongly intertwined with Pneumococcal vaccine, which is a subfield of Immunology. His work deals with themes such as Human pathogen and Pathogenesis, which intersect with Pneumococcal infections.
Microbiology, Streptococcus pneumoniae, Virulence, Pneumococcal infections and Pneumolysin are his primary areas of study. His Microbiology research is multidisciplinary, relying on both In vivo and Virology. Streptococcus pneumoniae is the subject of his research, which falls under Bacteria.
His studies deal with areas such as Toxin, Secretory protein, Pyruvate oxidase and Enzyme as well as Virulence. His research in Pneumococcal infections intersects with topics in Human pathogen and Immunology. His Pneumolysin research also works with subjects such as
Larry S. McDaniel mainly focuses on Streptococcus pneumoniae, Microbiology, Virulence, Pneumococcal infections and Antibiotic resistance. His biological study spans a wide range of topics, including Human pathogen and Virulence factor. His Virulence factor study combines topics from a wide range of disciplines, such as Penicillin, Sulfamethoxazole, Immunity and Trimethoprim.
His Microbiology study integrates concerns from other disciplines, such as Secretory protein, Pathogenesis and Escherichia coli. The various areas that Larry S. McDaniel examines in his Secretory protein study include Toxin, Pyruvate oxidase, Metabolism and Enzyme. Serotype is a subfield of Virology that Larry S. McDaniel explores.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae
Haley R. Pipkins;Jessica L. Bradshaw;Lance E. Keller;Edwin Swiatlo.
PLOS ONE (2017)
Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae
M. J. Crain;W. D. Waltman;J. S. Turner;J. Yother.
Infection and Immunity (1990)
PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.
L S McDaniel;J S Sheffield;P Delucchi;D E Briles.
Infection and Immunity (1991)
PspC, a pneumococcal surface protein, binds human factor H.
Sandhya Dave;Alexis Brooks-Walter;Michael K. Pangburn;Larry S. McDaniel.
Infection and Immunity (2001)
Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).
L S McDaniel;J Yother;M Vijayakumar;L McGarry.
Journal of Experimental Medicine (1987)
Pneumococcal Diversity: Considerations for New Vaccine Strategies with Emphasis on Pneumococcal Surface Protein A (PspA)
David E. Briles;Rebecca Creech Tart;Edwin Swiatlo;Joseph P. Dillard.
Clinical Microbiology Reviews (1998)
PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice.
David E. Briles;Janice D. King;Mary Ann Gray;Larry S. McDaniel.
Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.
L S McDaniel;G Scott;J F Kearney;D E Briles.
Journal of Experimental Medicine (1984)
Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260
L S McDaniel;B A Ralph;D O McDaniel;D E Briles.
Microbial Pathogenesis (1994)
Dual Roles of PspC, a Surface Protein of Streptococcus pneumoniae, in Binding Human Secretory IgA and Factor H
Sandhya Dave;Stephanie Carmicle;Sven Hammerschmidt;Michael K. Pangburn.
Journal of Immunology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: